Showing results 35 to 54 of 87
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 1996 | Heroin overdose: the case for take-home naltrexone | Strang, J.; Darke, S.; Hall, W.; Farrell, M.; Ali, R. |
| 2004 | HIV in injecting drug users in Asian countries | Wodak, A.; Ali, R.; Farrell, M. |
| 2005 | HIV in injecting drug users in Asian countries - Reply | Wodak, A.; Ali, R.; Farrell, M. |
| 2001 | Hyperalgesic responses in methadone maintenance patients | Doverty, M.; White, J.; Somogyi, A.; Bochner, F.; Ali, R.; Ling, W. |
| 1996 | Improvements in retention rates and changes in client groups with methadone maintenance streaming. | White, J.; Ryan, C.; Ali, R. |
| 2009 | Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation | Degenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R. |
| 2015 | Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids | Peacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L. |
| 2008 | Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS | Lawrinson, P.; Ali, R.; Buarvirat, A.; Chiamwongpaet, S.; Dvoryak, S.; Habrat, B.; Jie, S.; Mardiati, R.; Mokir, A.; Moskalewicz, J.; Newcombe, D.; Poznyak, V.; Subata, E.; Uchtenhagen, A.; Utami, D.; Vial, R.; Zhao, C. |
| 1999 | Laws applying to minor cannabis offences in Australia and their evaluation | Lenton, S.; McDonald, D.; Ali, R.; Moore, T. |
| 2018 | LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence | Ezard, N.; Dunlop, A.; Hall, M.; Ali, R.; McKetin, R.; Bruno, R.; Phung, N.; Carr, A.; White, J.; Clifford, B.; Liu, Z.; Shanahan, M.; Dolan, K.; Baker, A.L.; Lintzeris, N. |
| 2013 | Methadone at tapered doses for the management of opioid withdrawal | Amato, L.; Davoli, M.; Minozzi, S.; Ferroni, E.; Ali, R.; Ferri, M. |
| 2006 | Methadone treatment of injecting opioid users for prevention of HIV infection | Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R. |
| 2010 | Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management | Ali, R.; Marsden, J.; Srisurapanont, M.; Sunga, A.; Baigent, M.; Monteiro, M. |
| 2009 | National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence | Lintzeris, N.; Clark, N.; Muhleisen, P.; Ritter, A.; Ali, R.; Bell, J.; Gowing, L.; Hawkin, L.; Henry-Edwards, S.; Mattick, R.; Monheit, B.; Newton, I.; Quigley, A.; Whicker, S.; White, J.; Mattick, R.; Ali, R.; Lintzeris, N. |
| 2006 | One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS) | Teesson, M.; Ross, J.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R. |
| 2000 | Opioid antagonists and adrenergic agonists for the management of opioid withdrawal | Gowing, L.; Ali, R.; White, J. |
| 2010 | Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal | Gowing, L.; Ali, R.; White, J. |
| 2006 | Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review) | Gowing, L.; Ali, R.; White, J. |
| 2009 | Opioid antagonists with minimal sedation for opioid withdrawal | Gowing, L.; Ali, R.; White, J.; Gowing, L. |
| 2006 | Opioid antagonists with minimal sedation for opioid withdrawal (review) | Gowing, L.; Ali, R.; White, J.; Gowing, L. |
